Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
2.502
-0.058 (-2.27%)
Jun 29, 2026, 2:07 PM EDT - Market open
Adial Pharmaceuticals Employees
Adial Pharmaceuticals had 5 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,554,152
Market Cap
5.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| NextCure | 40 |
| PMGC Holdings | 34 |
| Aptevo Therapeutics | 33 |
| Genprex | 13 |
| Processa Pharmaceuticals | 12 |
| XTL Biopharmaceuticals | 10 |
| Dermata Therapeutics | 9 |
| CNS Pharmaceuticals | 8 |
ADIL News
- 13 days ago - Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing - GlobeNewsWire
- 14 days ago - Adial Pharmaceuticals initiated with a Buy at Lucid Capital - TheFly
- 18 days ago - Adial Pharmaceuticals Transcript: M&A announcement - Transcripts
- 18 days ago - Adial Pharmaceuticals Press release: M&A announcement - Filings
- 18 days ago - Adial Pharmaceuticals announces acquisition of Azora Therapeutics - TheFly
- 18 days ago - Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing - GlobeNewsWire
- 18 days ago - Adial Pharmaceuticals Slides: Corporate presentation - Filings
- 7 weeks ago - Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update - GlobeNewsWire